TCWA
FOLD

Ten Capital Wealth Advisors’s Amicus Therapeutics FOLD Stock Holding History

Ten Capital Wealth Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-85
Closed -$943 – 306
2023
Q1 		$943 Hold
85
– – ﹤0.01% 483
2022
Q4 		$1.04K Hold
85
– – ﹤0.01% 473
2022
Q3 		$1K Buy
85
+10
+13% +$111 ﹤0.01% 517
2022
Q2 		$1K Hold
75
– – ﹤0.01% 421
2022
Q1 		$1K Hold
75
– – ﹤0.01% 443
2021
Q4 		$1K Buy
75
+28
+60% +$312 ﹤0.01% 437
2021
Q3 		$0 Hold
47
– – ﹤0.01% 453
2021
Q2 		$0 Hold
47
– – ﹤0.01% 476
2021
Q1 		$0 Buy
+47
New +$727 ﹤0.01% 368

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Ten Capital Wealth Advisors's FOLD Position: Q2 2023 in Review

Ten Capital Wealth Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2023, closing a stake of 85 shares — an estimated $943 sold.

Ten Capital Wealth Advisors first reported a position in FOLD in Q1 2021 and held it in 9 quarters. The position peaked at $1.04K in Q4 2022. 216 funds tracked by Wall St. Rank hold FOLD as of Q2 2023.

  • Ten Capital Wealth Advisors reported no remaining Amicus Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Ten Capital Wealth Advisors sold 85 Amicus Therapeutics shares in Q2 2023, an estimated $943.
  • Ten Capital Wealth Advisors first reported a position in Amicus Therapeutics in Q1 2021 and held it in 9 quarters.
  • Ten Capital Wealth Advisors's Amicus Therapeutics position peaked at $1.04K in Q4 2022.
  • 216 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2023.

Based on Ten Capital Wealth Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.